Running another trial makes sense if “test subjects” are needed but giving the drug general availability when the previous trial failed and was actually stopped because of failure doesn’t make much sense to me.
In my mind, there are two main issues. The first is what other alternatives would be overlooked because of an approved treatment, including further research.
The other issue is money. These medicines cost a lot of money, and it there's no improvement it's a waste of resources not only for the patient, but also for the insurance pool they're in. If it's something that's not expensive, go nuts, but thousands of dollars to move the metric but not the symptoms doesn't make sense to me.
Everything in life is a gamble. How you interpret the results is you own undoing.
Also this drug is crazy expensive for something which doesn't even work.
The biggest problem is this is a gamble with other people's money because medicare and the taxpayers are on the hook for the bill.